arXiv · 2607.24084
Simulation-Free Bayesian Power and Sample Size Calculations for Bayes Factors in Single-Arm Phase II Trials with Binary Endpoints
Abstract
Bayes factors provide a coherent Bayesian measure of evidence for competing hypotheses and have recently been used as the basis for single-arm phase II trial designs with binary endpoints. In contrast to classical power analyses based on test statistics and p-values, Bayes-factor based sample size calculations target high probabilities of obtaining compelling evidence either for a relevant treatment effect or for the null hypothesis, given pre-specified Bayes-factor thresholds. This paper explains how to design single-arm phase II binomial trials using Bayes factors with a focus on simulation-free calibration of Bayesian and frequentist power, type-I-error, and the probability of compelling evidence for the null. Two oncology-motivated examples illustrate the approach and are implemented in the bfbin2arm R package, with code provided in an appendix. The methodology fits naturally into current efforts to innovate and modernize clinical trial design through Bayesian and adaptive methods.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Riko Kelter, Kathrin Möllenhoff. 2026-07-27. Simulation-Free Bayesian Power and Sample Size Calculations for Bayes Factors in Single-Arm Phase II Trials with Binary Endpoints. https://arxiv.org/abs/2607.24084
Cite the original work for its findings. Save a collection to share your selection of sources.